Connecticut is losing more bioscience jobs than it is gaining, despite a sizable jump in research and development jobs over the last three years. Alexion’s departure is the latest in a line that has undercut bioscience growth. Nonetheless, many say New Haven is nearing a “critical mass” after years of effort by Yale and a new cluster is emerging in Farmington after more than $1 billion in state investment.
While partisan politics has bogged down many state legislative debates, Democratic and Republican leaders announced Tuesday they can agree on how to better support and plan the growth of Connecticut’s bioscience industry.
The top executive as Connecticut’s quasi-public economic development agency, Claire Leonardi, will step down next month, the board of directors for Connecticut Innovations announced Thursday.
Despite their seeming ability to disagree about almost everything, Gov. Danel P. Malloy and Tom Foley share plenty of common ground about Connecticut’s future economic development. But it’s their respective track records that lead them to butt heads most frequently.